These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6483122)

  • 21. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
    Edwards E; Ashby CR; Wang RY
    Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sites.
    Gandolfi O; Barbaccia ML; Costa E
    Life Sci; 1985 Feb; 36(8):713-21. PubMed ID: 2983168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of potential alpha-helix in the G loop of the guinea pig 5-hydroxytryptamine2 receptor does not prevent receptor coupling to phosphoinositide hydrolysis.
    Watts SW; Cohen ML; Mooney PQ; Johnson BG; Schoepp DD; Baez M
    J Neurochem; 1994 Mar; 62(3):934-43. PubMed ID: 8113814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells.
    Aune TM; Kelley KA; Ranges GE; Bombara MP
    J Immunol; 1990 Sep; 145(6):1826-31. PubMed ID: 2144010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin type 2 antagonists inhibit lordosis behavior in the female rat: reversal with quipazine.
    Mendelson SD; Gorzalka BB
    Life Sci; 1986 Jan; 38(1):33-9. PubMed ID: 2934598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus.
    Offord SJ; Warwick RO
    Eur J Pharmacol; 1984 Sep; 104(3-4):379-82. PubMed ID: 6499929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis toxin treatment prevents 5-HT(5a) receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells.
    Thomas EA; Matli JR; Hu JL; Carson MJ; Sutcliffe JG
    J Neurosci Res; 2000 Jul; 61(1):75-81. PubMed ID: 10861802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central serotonin receptors: effector systems, physiological roles and regulation.
    Conn PJ; Sanders-Bush E
    Psychopharmacology (Berl); 1987; 92(3):267-77. PubMed ID: 2819915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CGS 18102A, a benzopyranopyridine anxiolytic with 5-HT1 agonist and 5-HT2 antagonist properties.
    Sills MA; Bennett DA; Lovell RA; Liebman JM; Wood PL; Glaeser BS; Williams M; Hutchison AJ
    Prog Clin Biol Res; 1990; 361():469-75. PubMed ID: 1981265
    [No Abstract]   [Full Text] [Related]  

  • 31. Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells.
    Doyle VM; Creba JA; Rüegg UT; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):98-103. PubMed ID: 2944005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.
    Roth BL; Nakaki T; Chuang DM; Costa E
    J Pharmacol Exp Ther; 1986 Aug; 238(2):480-5. PubMed ID: 3016238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methoctramine, a cardioselective muscarinic antagonist, stimulates phosphoinositide hydrolysis in rat cerebral cortex.
    Lee NH; Forray C; el-Fakahany EE
    Eur J Pharmacol; 1989 Aug; 167(2):295-8. PubMed ID: 2556288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketanserin does not prevent ACTH-induced hypertension in sheep.
    Nelson MA; Coghlan JP; Denton DA; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1985; 12(2):155-9. PubMed ID: 2988838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
    Claustre Y; Eudeline B; Benavides J; Scatton B
    Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.
    Aune TM; Golden HW; McGrath KM
    J Immunol; 1994 Jul; 153(2):489-98. PubMed ID: 8021490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA; Peroutka SJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of 5-hydroxytryptamine-stimulated phosphoinositide hydrolysis in the rat cerebral cortex by repeated immobilization stress.
    Okuyama N; Morinobu S; Totsuka S; Endoh M
    Eur J Pharmacol; 1995 Oct; 285(1):61-7. PubMed ID: 8846812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists.
    Rashid M; Watanabe M; Nakazawa M; Nakamura T; Hattori K; Nagatom T
    Jpn J Pharmacol; 2001 Nov; 87(3):189-94. PubMed ID: 11885967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.